Resveratrol: An assessment of its dose response an introduction

Mochly-Rosen D. , Zakhari S. Focus on: the cardiovascular system what did we learn from the French (paradox)? Alcoh Res Health 2010; 33: 76-86.

Ramprasath VR , Jones PJH. Anti-atherogenic effects of resveratrol . Eur J Clin Nutr 2010; 64: 660-668.

Tosun I. , Inkaya AN Resveratrol as a health and disease benefit agent. Food Rev Intern 2010; 26: 85-101.

Sun AY , Wang Q. , Simonyi A. , and Sun GY Resveratrol as a therapeutic agent for neurodegenerative diseases . Mol Neurobiol 2010; 41: 375-383.

Yusuf N. , Nasti TH , Meleth S. , and Elmets CA Resveratrol enhances cell-mediated immune response to DMBA through TLR4 and prevents DMBA induced cutaneous carcinogenesis. Mol Carcinog 2009;48: 713-723.

Alfaras I. , Juan ME , and Planas JM Trans-resveratrol reduces precancerous colonic lesions in dimethylhydrazine-treated rats. J Agri Food Chem. 2010; 58: 8104-8110.

Imai SI A possibility of nutriceuticals as an anti-aging intervention: activation of sirtuins by promoting mammalian NAD biosynthesis. Pharmacol Res 2010; 62: 42-47.

Calabrese EJ BELLE: an evolving legacy. A brief history of BELLE. Hum Exper Toxicol 2010; 29: 247-248.

Calabrese EJ Getting the dose response wrong. Why hormesis became marginalized and the threshold model accepted. Arch Toxicol 2009; 83: 227-247.

Calabrese EJ The road to linearity: why linearity at low doses became the basis for carcinogen risk assessment. Arch Toxicol 2009; 83: 203-225.

Calabrese EJ , Baldwin LA Toxicology rethinks its central belief-hormesis demands a reappraisal of the way risks are assessed. Nature 2003; 421: 691-692.

Calabrese EJ , Baldwin LA The hormetic dose response model is more common than the threshold model in toxicology. Toxicol Sci 2003; 71: 246-250.

Calabrese EJ , Baldwin LA Hormesis: U-shaped dose-response and their centrality in toxicology. Trends Pharmacol Sci 2001; 22: 285-291.

Calabrese EJ , Blain R. The occurrence of hormetic dose responses in the toxicological literature, the hormesis database: an overview . Toxicol Appl Pharmacol 2005; 202: 289-301.

Calabrese EJ , Baldwin LA Hormesis: the dose-response revolution . Ann Rev Pharmacol Toxicol 2003c; 43: 175-197.

Calabrese EJ , Baldwin LA The frequency of U-shaped dose responses in the toxicological literature. Toxicol Sci 2001; 62: 330-338.

Calabrese EJ , Hoffmann GR , Stanek EJ , and Nascarella MA Hormesis in high-throughput screening of antibacterial compounds in E. coli. Hum Exp Toxicol 2010; 29: 667-677.

Calabrese EJ , Stanek EJ 3rd, Nascarella MA , and Hoffmann GR Hormesis predicts low-dose responses better than threshold models. Int J Toxicol 2008; 27: 369-378.

Calabrese EJ , Staudenmayer JW , Stanek EJ , and Hoffmann GR Hormesis outperforms threshold model in NCI anti-tumor drug screening data. Toxicol Sci 2006; 94: 368-378.